Revitalizing new product development from clinical trials through FDA review :
hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996.
|Corporate Author:||United States.|
Washington : U.S. G.P.O. : 1996.
United States. /
Food and Drug Administration.
Drug Evaluation > Drug Evaluation / legislation & jurisprudence > Drug Evaluation / legislation & jurisprudence / United States.
Biological products > Biological products / Safety regulations > Biological products / Safety regulations / United States.
Medical instruments and apparatus > Medical instruments and apparatus / Safety regulations > Medical instruments and apparatus / Safety regulations / United States.
Drugs > Drugs / Testing > Drugs / Testing / Law and legislation > Drugs / Testing / Law and legislation / United States.
Drugs > Drugs / Law and legislation > Drugs / Law and legislation / United States.
Shipping list no.: 96-0240-P.
Distributed to some depository libraries in microfiche.
iii, 230 p. :
|Locate a Print Version:||
Find in a library
|Item Link||Original Source|
|Full view||University of Michigan|
|Full view||University of California|
|Full view4.L 11/4:S.HRG.104-444||Pennsylvania State University|